They have received the results from the 3rd party, there are a number of staff with degrees in their field who should be able to have this data ready to present to investors before the CR. I think the "missed projections" argument has been and gone, it's now in their hands, if the results are good there is no reason for them not to release a well put together press release saying here are our findings from the phase 2 human trials, now let us raise credit to the tune of 30,000,000 diluting shares and options rather than 70,000,000 because we know how to run a business.
CR before results=poor results?, page-7
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.001(1.89%) |
Mkt cap ! $48.72M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $6.98K | 133.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 151165 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 86242 | 1 |
View Market Depth
| Last trade - 15.32pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.2¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 5.3¢ | 5.3¢ | 5.2¢ | 38302 | ||
| Last updated 11.25am 24/05/2024 ? | |||||
| BIT (ASX) Chart |